Document:

EX-10.1

 Exhibit 10.1 

SECOND AMENDED AND RESTATED 

EMPLOYMENT AGREEMENT 
 This
Second Amended and Restated Employment Agreement (this “Agreement”) is made and entered into on April 25, 2022, effective as of the Effective Date (as defined below), by and between CCC Intelligent Solutions Holdings Inc., a
Delaware corporation (together with any of its subsidiaries and affiliates as may employ Employee from time to time and any successor(s) thereto, the “Company”), and Barrett J. Callaghan (“Employee”). 

WHEREAS, Employee and Cypress Intermediate Holdings III, Inc., a Delaware corporation and predecessor entity to the Company, are party to that
certain Amended and Restated Employment Agreement, dated as of April 27, 2017 (the “Prior Agreement”); 
 WHEREAS, the
Company desires to continue to employ the Employee, and the Employee hereby desires to continue to be employed by the Company, on a part-time basis, pursuant to the terms and conditions contained in this Agreement, which shall supersede the Prior
Agreement in its entirety effective as of the Effective Date; 
 WHEREAS, Employee and the Company are parties to (i) that certain
Restricted Stock Unit Grant Notice and Restricted Stock Unit Grant Agreement (collectively, the “RSU Agreement”), (ii) that certain Performance Restricted Stock Unit (Revenue CAGR) Grant Notice and Performance Restricted Stock Unit
(Revenue CAGR) Grant Agreement (collectively, the “CAGR PSU Agreement”), and (iii) that certain Performance Restricted Stock Unit (TSR) Grant Notice and Performance Restricted Stock Unit (TSR) Grant Agreement (collectively, the
“TSR PSU Agreement,” and together with the RSU Agreement and the CAGR PSU Agreement, the “Grant Agreements”), each dated as of October 21, 2021; and 

WHEREAS, effective as of the Effective Date, Employee and the Company desire to amend each of the Grant Agreements, pursuant to the terms and
conditions contained in Section 3.3 of this Agreement. 
 NOW, THEREFORE, in consideration of the foregoing, and
for other good and valuable consideration, including the respective covenants and agreements set forth below, the parties hereto agree as follows: 

1. Position. During the Period of Employment (as defined below), Employee shall serve in the capacity indicated on Exhibit A
attached hereto. Employee shall perform such duties and responsibilities as the Chief Executive Officer of the Company may assign to Employee from time to time. During the Period of Employment, Employee shall report to the Chief Executive Officer of
the Company. Employee’s role as a Section 16 Officer of the Company and all related duties will cease effective as of the Effective Date (as defined below). During the Period of Employment, Employee will (a) during normal business
hours, devote at least twenty-five percent (25%) of Employee’s time and attention to, and use Employee’s best efforts to advance, the business and welfare of the Company, and (b) not engage in any outside full-time employment or other
business activities for any direct or indirect remuneration without the prior written consent of the Chief Executive Officer of the Company, which consent shall not be unreasonably withheld; provided, that Employee may engage in charitable
activities during the Period of Employment; provided, further, that such charitable activities shall not (i) be inconsistent with Employee’s duties hereunder, (ii) violate Section 8.1(a) hereof, or
(iii) create a potential business or fiduciary conflict. 

  
 1 

 2. Period of Employment. The Company hereby agrees to continue to employ Employee,
and Employee hereby agrees to continue to be in the employ of the Company, on a part-time basis as described in Section 1 hereof, for the period commencing as of May 31, 2022 (the “Effective Date”) and
ending on the third (3rd) anniversary of the Effective Date (the “Anniversary Date”), subject to earlier termination pursuant to Section 6 hereof (the “Period of Employment”). The Period of
Employment and Employee’s employment with the Company shall automatically terminate effective as of the Anniversary Date. For the avoidance of doubt, prior to the Effective Date, the terms and conditions of Employee’s employment with the
Company shall continue to be governed by the Prior Agreement. In the event that the Prior Agreement is terminated by either party for any reason prior to the Effective Date, this Agreement shall be null and void ab initio. 

3. Compensation. 
 3.1
Base Salary. During the Period of Employment, the Company shall pay Employee a per annum base salary as set forth in Exhibit A (as may be adjusted from time to time by the Company in its sole discretion, the “Base
Salary”) payable in accordance with the standard policies of the Company. For the avoidance of doubt, Employee’s Base Salary shall not be subject to increase during the Period of Employment. 

3.2 Annual Bonus. During the Period of Employment, Employee shall not be eligible to participate in the Company’s annual cash
bonus program or receive any performance-based cash bonus from the Company; provided, however, that Employee shall be eligible to receive a pro-rated annual bonus for calendar year 2022 equal to $109,721 (the
“Prorated Bonus”), payable at the same time that 2022 annual bonuses are paid to similarly-situated Company employees generally in calendar year 2023. For the avoidance of doubt, to receive the Prorated Bonus, Employee is required
to be employed with the Company on the date that the Prorated Bonus is paid. 
 3.3 Equity-Based Compensation. 

(a) Pursuant to the Grant Agreements, and subject to the Company’s 2021 Incentive Equity Plan, as amended from time to time (the
“Incentive Plan”), on October 21, 2021 Employee received (i) 137,500 RSUs (as defined in the RSU Grant Agreement), (ii) 68,750 PSUs (as defined in the CAGR PSU Agreement, the “CAGR PSUs”) and (iii) and
68,750 PSUs (as defined in the TSR PSU Agreement, the “TSR PSUs”). The Company and Employee hereby acknowledge and agree that none of the RSUs, CAGR PSUs or TSR PSUs will have vested as of the Effective Date. 

(b) Notwithstanding anything to the contrary in the applicable Grant Agreement, effective as of the Effective Date: 

  
 2 

 (i) (1) 68,750 of the RSUs granted under the RSU Agreement shall be immediately forfeited
for no consideration therefor, and Employee’s rights in any such RSUs shall lapse and expire, (2) 34,375 of the CAGR PSUs granted under the CAGR PSU Agreement shall be immediately forfeited for no consideration therefor, and Employee’s
rights in any such CAGR PSUs shall lapse and expire, and (3) 34,375 of the TSR PSUs granted under the TSR PSU Agreement shall be immediately forfeited for no consideration therefor, and Employee’s rights in any such TSR PSUs shall lapse and
expire. 
 (ii) After giving effect to the forfeiture provisions set forth above in Section 3.3(b)(i), the
remaining unvested RSUs, CAGR PSUs and TSR PSUs shall continue to be eligible to vest during the Period of Employment in accordance with the vesting schedule set forth in the applicable Grant Agreement; provided, that upon the expiration of the
Period of Employment for any reason or no reason, any then-unvested RSUs, CAGR PSUs and/or TSR PSUs shall be immediately forfeited for no consideration therefor, and Employee’s rights in any such unvested RSUs, CAGR PSUs and/or TSR PSUs shall
lapse and expire. 
 (c) Except as expressly provided in this Agreement, the RSUs, CAGR PSUs, and TSR PSUs shall remain subject to all
other terms of the applicable Grant Agreement. 
 (d) For the avoidance of doubt, (i) nothing in this Agreement is intended to, nor
shall it, amend any of the terms or conditions contained in those certain Stock Option Grant Agreements entered into by and between Employee and the Company, dated as of July 10, 2017 and April 1, 2020, and (ii) during the Period of
Employment, Employee shall not be eligible to receive any new equity awards under the Incentive Plan or any successor plan of the Company. 

4. Benefits. 
 4.1 During
the Period of Employment, Employee shall be eligible to participate in benefit plans and programs as the Company may from time to time offer to its part-time employees; provided, that in no event shall Employee be eligible to participate in any
severance plan or program of the Company, subject to Section 6.4 hereof. Employee’s right to participate in such plans and programs shall not affect the Company’s right to amend or terminate any such plan and
program. For the avoidance of doubt, nothing in this Agreement is intended to, nor shall it, impact Employee’s right to continued coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”),
as a result of Employee’s transition from a full-time employee of the Company to a part-time employee of the Company. 
 4.2 During the
Period of Employment, subject to Employee’s timely election of continued coverage under COBRA, the Company shall pay Employee a monthly cash payment equal to $1,500, payable in accordance with the standard policies of the Company, to be used by
Employee to subsidize Employee’s monthly COBRA premiums (the “COBRA Payments”); provided, that (a) Employee is eligible and remains eligible for COBRA coverage, (b) the Company may modify the COBRA Payments to
the extent reasonably necessary to avoid the imposition of any excise taxes on the Company for failure to comply with the non-discrimination requirements of Section 105(h) of the Internal Revenue Code of
1986, as amended, the Patient Protection and Affordable Care Act of 2010, as amended, and/or the Health Care and Education Reconciliation Act of 2010, as amended, and in each case, the regulations and guidance promulgated thereunder (to the extent
applicable), and (c) in the event that Employee obtains other employment that offers group health benefits, the COBRA Payments shall immediately cease. 

  
 3 

 5. Expenses. Upon presentation of acceptable substantiation therefor, the Company
will pay or reimburse Employee for such reasonable travel, entertainment and other expenses as Employee may incur during the Period of Employment in connection with the performance of Employee’s duties hereunder. 

6. Termination of Employment. 

6.1 Termination, Notice and Accrued Benefits. The parties hereto expressly agree that Employee’s employment may be terminated by
either (i) the Company immediately upon written notice to Employee for Cause or (ii) Employee upon thirty (30) days’ advance written notice to the Company and that, upon any such termination, Employee shall not be entitled to any
payment in the nature of severance or otherwise except for the following: (i) any earned but unpaid Base Salary, payable within thirty (30) days following such date of termination, (ii) any unreimbursed business expenses incurred
through such date of termination, payable within thirty (30) days following such date of termination, and (iii) any amounts or benefits due under any benefit plan, program or arrangement of the Company, in accordance with the terms
contained therein (collectively, the “Accrued Benefits”). As used herein, “Cause” means that Employee (i) has been convicted of a felony, or has entered a plea of guilty or nolo contendere to a felony, (ii) has
committed an act of fraud involving dishonesty which is injurious to the Company or any of its subsidiaries, (iii) has willfully and continually refused to perform his duties with the Company or any of its subsidiaries or (iv) has engaged
in misconduct that is materially injurious to the Company or any of its subsidiaries. 
 6.2 Death or Disability. Employee’s
employment with the Company and the Period of Employment, and all rights to compensation under this Agreement other than the Accrued Benefits, shall automatically terminate upon the death or Disability (as defined below) of Employee, except for such
death or disability payments as may be payable under any applicable benefit plans maintained at that time by the Company. As used herein, “Disability” means the Board of Directors of the Company (the “Board”) has
made a good faith determination that Employee has become physically or mentally incapacitated or disabled such that Employee is unable to perform for the Company substantially the same services as Employee performed prior to incurring such
incapacity or disability, and such incapacity or disability exists for an aggregate of one-hundred and twenty (120) calendar days in any twelve (12) month period. In connection with making such
determination, the Company, at its option and expense, shall be entitled to select and retain a physician to confirm the existence of such incapacity or disability, and the determination made by such physician shall be binding on the parties for the
purposes of this Agreement. 
 7. Release. The Company’s obligations set forth in Section 3, Section 4 of this
Agreement are subject to and conditioned upon the Release Condition and the Second Release Condition (each as defined below). 
  

  
 4 

 7.1 General. In consideration for entering into this Agreement and the compensation
and benefits to be provided hereunder, including, without limitation, the continued vesting of Employee’s equity awards as contemplated in Section 3.3 hereof, Employee agrees to execute and deliver to the Company a
general release of claims in the form attached hereto as Exhibit B (the “Release”) that has become irrevocable within the required timeframe specified in this Section 7.1 within thirty (30) days
of the Effective Date (the “Release Condition”). Employee acknowledges that (i) the Company has advised Employee that Employee should consult with an attorney prior to executing and
re-executing the Release (as applicable), (ii) Employee has carefully read and fully understands all of the provisions of the Release, (iii) Employee is entering into the Release knowingly, freely and
voluntarily in exchange for good and valuable consideration to which Employee would not be entitled in the absence of executing or re-executing (as applicable) and not revoking the Release, and
(iv) Employee has been given at least twenty-one (21) calendar days to consider the terms of the Release, although Employee may execute it at any time sooner. Employee has seven (7) calendar
days after the date on which Employee initially executes the Release to revoke Employee’s consent to the Release. Such revocation must be in writing and must be emailed to legal@cccis.com. Notice of such revocation must be received within the
seven (7) calendar day period referenced above. If Employee does not execute the Release within thirty (30) days of the Effective Date, or if Employee revokes such execution, this Agreement shall be null and void and neither the Company
nor Employee shall have any rights or obligations under it. 
 7.2 Re-Execution. Employee
agrees to re-execute and deliver to the Company the Release that has become irrevocable within the required timeframe specified in this Section 7.2 within thirty (30) days
following the expiration of the Period of Employment for any reason or no reason (the “Second Release Condition”). Upon Employee’s re-execution of the Release (the “Re-Execution Date”), Employee advances to the Re-Execution Date Employee’s release of all Claims (as defined in the Release). Employee has seven
(7) calendar days from the Re-Execution Date to revoke Employee’s re-execution of the Release. Such revocation must be in writing and must be emailed to
legal@cccis.com. Notice of such revocation must be received within the seven (7) calendar day period referenced above. 
 8. Non-Competition; Non-Disclosure of Proprietary Information, Surrender of Records; Inventions and Patents. 

8.1 Non-Competition. 

(a) Employee acknowledges that, in the course of Employee’s employment with the Company, (i) Employee has been and will continue to
be familiar with trade secrets and other proprietary information of the Company which, if disclosed, would unfairly and inappropriately assist in competition against the Company, (ii) Employee’s services have been and will continue to be
of special, unique and extraordinary value to the Company, and (iii) Employee has generated and will continue to generate goodwill for the Company. Therefore, Employee agrees that, during Employee’s employment or service with the Company
and for twelve (12) months thereafter (the “Restricted Period”), Employee shall not directly or indirectly own, manage, control, participate in, consult with, render services for, or in any manner engage with, any business
competing with any business of the Company within the United States and any other geographical area in which the Company then engages in business or engaged in business at any time during Employee’s employment with the Company. Nothing herein
shall prohibit Employee from being a passive owner of not more than two percent (2%) of the outstanding stock of any class of a corporation which is publicly traded, so long as Employee has no direct or indirect active participation in the business
of such corporation. 

  
 5 

 (b) During the Restricted Period, Employee shall not directly or indirectly (i) induce
or attempt to induce any employee or service provider of the Company to terminate such employment or service, or in any way interfere with the employee or service relationship between the Company and any such individual, (ii) hire any person
who is, or at any time during the eighteen (18)-month period immediately prior to the date of Employee’s termination of employment was, an employee or service provider of the Company or (iii) induce or attempt to induce any person having a
business relationship with the Company to cease doing business with the Company or interfere materially with the relationship between any such person and the Company. 

8.2 Proprietary Information. During the Period of Employment and at all times thereafter, Employee agrees that Employee shall not use
any Proprietary Information for Employee’s own purpose or for the benefit of any person or entity other than the Company or its shareholders or affiliates, nor shall Employee otherwise disclose any Proprietary Information to any individual or
entity, unless such disclosure (a) has been authorized by the Board, (b) is reasonably required within the course and scope of Employee’s employment hereunder or (c) is required by law, a court of competent jurisdiction or a
governmental or regulatory agency. For purposes of this Agreement, “Proprietary Information” shall mean: (i) the name or address of any customer, supplier or affiliate of the Company or any information concerning the
transactions or relations of any customer, supplier or affiliate of the Company or any of its shareholders; (ii) any information concerning any product, service, technology or procedure offered or used by the Company, or under development by or
being considered for use by the Company; (iii) any information relating to marketing or pricing plans or methods, capital structure, or any business or strategic plans of the Company, (iv) any inventions, innovations, trade secrets or
other items covered by Section 8.4 hereof; and (v) any other information which the Board has determined in its sole discretion and communicated to Employee in writing to be proprietary information for purposes hereof.
Notwithstanding the foregoing, Proprietary Information shall not include any information that is or becomes generally known to the public other than through actions of Employee in violation of this Section 8. 

8.3 Surrender of Records. Employee agrees that Employee shall not retain and shall promptly surrender to the Company all
correspondence, memoranda, files, manuals, financial, operating or marketing records, magnetic tape, or electronic or other media of any kind which may be in Employee’s possession or under Employee’s control or accessible to Employee which
contain any Proprietary Information. 
 8.4 Inventions and Patents. Employee agrees that all inventions, innovations, trade secrets,
patents and processes in any way relating, directly or indirectly, to the Company’s business developed by Employee alone or in conjunction with others at any time during Employee’s employment or service with the Company shall belong to the
Company. Employee will use Employee’s best efforts to perform all actions reasonably requested by the Board to establish and confirm such ownership by the Company. 

8.5 Definition of Company. For purposes of this Section 8, the term “Company” shall include
the Company and any and all of its parents, subsidiaries, joint ventures and affiliated entities as the same may exist from time to time. 

  
 6 

 8.6 Enforcement. The parties hereto agree that the duration and area for which the
covenants set forth in this Section 8 are to be effective are reasonable. In the event that any court or arbitrator determines that the time period or the area, or both of them, are unreasonable and that any of the
covenants are to that extent unenforceable, the parties hereto agree that such covenants will remain in full force and effect, first, for the greatest time period, and second, in the greatest geographical area that would not render them
unenforceable. The parties intend that this Agreement will be deemed to be a series of separate covenants, one for each and every county of each and every state of the United States of America. Employee agrees that damages are an inadequate remedy
for any breach of the covenants in this Section 8 and that the Company will, whether or not it is pursuing any potential remedies at law, be entitled to equitable relief in the form of preliminary and permanent injunctions
without bond or other security upon any actual or threatened breach of this Agreement. 
 9. Whistleblower Protection.
Notwithstanding anything to the contrary contained herein, no provision of this Agreement shall be interpreted so as to impede Employee (or any other individual) from (i) participating, cooperating or testifying in any action, investigation or
proceeding with, or providing information to, any governmental agency or entity, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or (ii) making
any disclosure of relevant and necessary information or documents in any action, investigation or proceeding relating to this Agreement, or as required by law or legal process, including with respect to possible violations of law,
(iii) accepting any U.S. Securities and Exchange Commission Awards, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. Nothing in this Agreement or any other agreement or Company policy
prohibits or restricts Employee from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or
regulation. Employee does not need the prior authorization of the Company to make any such reports or disclosures and Employee shall not be required to notify the Company that such reports or disclosures have been made. 

10. Trade Secrets. 18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or civilly liable under any
Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the
purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing in this Agreement is intended to
conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to disclose in confidence trade secrets to
federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other
proceeding, but only if the filing is made under seal and protected from public disclosure. 
 11. Section 409A of the
Code. It is the intent of the parties to this Agreement that the provisions of this Agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and this Agreement shall be construed and
interpreted in compliance with Section 409A of the Code and the Department of Treasury Regulations and other interpretive guidance issued thereunder (collectively, “Section 409A”). Notwithstanding any
provision of this 

  
 7 

 
Agreement to the contrary, in the event that the Company determines that any amounts payable hereunder will be immediately taxable to Employee under Section 409A, the Company reserves the
right (without any obligation to do so or to indemnify Employee for failure to do so) to (a) adopt such amendments to this Agreement and appropriate policies and procedures, including amendments and policies with retroactive effect, that the
Company determines to be necessary or appropriate to preserve the intended tax treatment of the benefits provided by this Agreement, to preserve the economic benefits of this Agreement and to avoid less favorable accounting or tax consequences for
the Company and/or (b) take such other actions as the Company determines to be necessary or appropriate to exempt the amounts payable hereunder from Section 409A or to comply with the requirements of Section 409A and thereby avoid the
application of penalty taxes thereunder. No provision of this Agreement shall be interpreted or construed to transfer any liability for failure to comply with the requirements of Section 409A from Employee or any other individual to the Company
or any of its affiliates, employees or agents. In the event that any payment to Employee or any benefit hereunder that is subject to Section 409A is made upon, or as a result of, Employee’s termination of employment with the Company, and
Employee is a “specified employee” (as that term is defined under Section 409A) at the time Employee becomes entitled to any such payment or benefit, no such payment or benefit will be paid or commenced to be paid to Employee under
this Agreement until the date that is the earlier to occur of (i) Employee’s death or (ii) six (6) months and one day following Employee’s termination of employment with the Company (the “Delay Period”). Any
payments which Employee would otherwise have received during the Delay Period will be payable to Employee in a lump sum on the date that is six (6) months and one day following the effective date of the termination, and any remaining
compensation and benefits due under the Agreement shall be paid or provided as otherwise set forth herein. Each separately identified amount and each installment payment to which Employee is entitled to payment shall be deemed to be a separate
payment for purposes of Section 409A. Notwithstanding any provision to the contrary in this Agreement, to the extent that any reimbursement of expenses or in-kind benefits constitutes “deferred
compensation” under Section 409A, such reimbursement or benefit shall be provided no later than December 31 of the year following the year in which the expense was incurred. The amount of expenses reimbursed in one year shall not
affect the amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind
benefits provided in any other year. 
 12. Miscellaneous. 

12.1 Notice. Any notice required or permitted to be given hereunder shall be deemed sufficiently given if sent by registered or
certified mail, postage prepaid, addressed to the addressee at the address last provided to the sender in writing by the addressee for purposes of receiving notices hereunder or, unless or until such address shall be so furnished, to the address
indicated opposite addressee’s signature to this Agreement. 
 If to Employee: 

At the address (or to the facsimile number) shown in the books and records of the Company. 

If to the Company: 
 CCC
Intelligent Solutions Holdings Inc. 
 167 N. Green St., 9th Floor, Chicago, IL 60607

  
 8 

 12.2 Tax Withholding. The Company may withhold from any amounts payable under this
Agreement such federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. 

12.3 Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or
enforceability of any other provision of this Agreement. 
 12.4 Modification and No Waiver of Breach. No waiver or modification of
this Agreement shall be binding unless it is in writing, approved by the Board and signed by the parties hereto. No waiver by a party of a breach hereof by the other party shall be deemed to constitute a waiver of a future breach, whether of a
similar or dissimilar nature, except to the extent specifically provided in any written waiver under this Section 12.4. 

12.5 Governing Law. This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of
Delaware (without regard to principles of conflicts of laws), and all questions relating to the validity and performance hereof and remedies hereunder shall be determined in accordance with such law. 

12.6 Counterparts. This Agreement may be executed by facsimile in two counterparts, each of which shall be deemed an original, but both
of which taken together shall constitute one and the same Agreement. 
 12.7 Captions. The captions used herein are for ease of
reference only and shall not define or limit the provisions hereof. 
 12.8 Entire Agreement. This Agreement and the Grant Agreements
(as amended herein), other than the non-competition and non-solicitation provisions in the Grant Agreements, which are superseded here, constitute the entire agreement
between the parties hereto relating to the matters encompassed hereby and supersede any prior oral or written agreements relating to such matters, including, without limitation, the Prior Agreement. The parties hereto acknowledge and agree that, as
of the Effective Date, the Prior Agreement shall be terminated and of no further force and effect. 
 12.9 Assignment. This Agreement
shall not be assigned by Employee, and may be assigned by the Company to any of its subsidiaries or affiliates, or any entity that succeeds to the business of the Company; provided, that an assignment to a subsidiary or affiliate by the Company
shall not relieve the Company of any of its obligations hereunder. 
 12.10 Non-Transferability
of Interest. None of the rights of Employee to receive any form of compensation payable pursuant to this Agreement shall be assignable or transferable except through a testamentary disposition or by the laws of descent and distribution upon the
death of Employee. Any other attempted assignment, transfer, conveyance or other disposition of any interest in the rights of Employee to receive any form of compensation to be made by the Company pursuant to this Agreement shall be void. 

[signature page follows] 
  

  
 9 

 IN WITNESS WHEREOF, this Agreement has been duly executed as of the date first above
written. 
  

			
	CCC INTELLIGENT SOLUTION
	HOLDINGS INC.
		
	By:	 	 /s/ Githesh Ramamurthy

	Name: Githesh Ramamurthy
	Title:   Chairman and Chief Executive Officer
	
	EMPLOYEE
		
	By:	 	 /s/ Barrett J. Callaghan

	Name: Barrett J. Callaghan

 [Signature Page to Employment Agreement] 

 EXHIBIT A 

to 
 Employment Agreement

  

			
		
	Name of Employee:	  	Barrett J. Callaghan
		
	Title:	  	Senior Advisor, Markets and Customer Success
		
	Base Salary:	  	$60,000.00 per annum

 EXHIBIT B 

to 
 Employment Agreement

 GENERAL RELEASE 

1. Release and Waiver. In consideration for entering into that certain Second Amended and Restated Employment Agreement, by and between
CCC Intelligent Solutions Holdings Inc., a Delaware corporation (the “Company” or “CCC”) and Barrett J. Callaghan (“Employee”), dated as of April 25, 2022 (the “Employment
Agreement”), and the compensation and benefits to be provided under the Employment Agreement, including, without limitation, the continued vesting of Employee’s equity awards as contemplated in Section 3.3 of the Employment
Agreement, Employee (for Employee, Employee’s agents, assigns, heirs, executors, and administrators) hereby releases and discharges CCC from any claim, demand, action, or cause of action, known or unknown, which arose at any time from the
beginning of time to the date Employee executes this Release (as defined in the Employment Agreement), and waives all claims relating to, arising out of, or in any way connected with Employee’s employment with CCC including, without limitation,
any claim, demand, action, cause of action, including money damages and claims for attorneys’ fees, based on but not limited to (collectively, the “Claims”): 

(a) The Age Discrimination in Employment Act of 1967; 

(b) The Americans with Disabilities Act of 1990, as amended, (“ADA”), 42 U.S.C. § 12101, et seq.; 

(c) The Rehabilitation Act of 1973, as amended, 29 U.S.C. § 701, et seq.; 

(d) The Family and Medical Leave Act of 1993, as amended, 29 U. S .C. § 2601, et seq.; 

(e) The Coronavirus Aid, Relief, and Economic Security (“CARES”) Act, Pub.L.116-136;
the Families First Coronavirus Response Act (“FFCRA”), Pub.L.116-127; and any other local, city, state or federal COVID-19 related laws; 

(f) The Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2000ff, et seq.; 

(g) The Employee Retirement Income Security Act, as amended, 29 U.S.C. § 1001, et seq.; 

(h) The Civil Rights Act of 1866, as amended, 42 U.S.C. § 1981; 

(i) Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000(e), et seq.; 

(j) The Equal Pay Act, as amended, 29 U.S.C. § 206, et seq.; 

 (k) The Immigration Reform and Control Act 

(l) The Worker Adjustment and Retraining Notification Act, as amended, 29 U.S.C. § 2101, et seq.; 

(m) The National Labor Relations Act, 29 U.S.C. § 151 et seq.; 

(n) Any existing or potential entitlement under any CCC program or plan, including wages or other paid leave; 

(o) Any existing or potential agreement, contract, representation, policy, procedure, or statement (whether any of the foregoing are express
or implied, oral or written); 
 (p) Any claims for quantum meruit, unjust enrichment, breach of oral promise, tortious interference with
business relations, defamation, negligent or intentional infliction of emotional distress, and any other common law contract and tort claims; 

(q) Any claims for unpaid or lost benefits, salary, bonuses, commissions, stock, stock options, payouts, vacation pay, severance pay, business
expenses, or other compensation; 
 (r) Any claims for attorneys’ fees, costs, disbursements, or other expenses; 

(s) Any claims for damages or personal injury; 

(t) Claims arising under any other federal, state and local fair employment practices law, disability benefits law, and any other employee or
labor relations statute, executive order, law or ordinance, and any duty or other employment-related obligation, claims arising from any other type of statute, executive order, law or ordinance, claims arising from contract or public policy, as well
as tort, tortious cause of conduct, breach of contract, intentional infliction of emotional distress, negligence, discrimination, harassment, and retaliation, including common law retaliatory discharge, together with all claims for monetary and
equitable relief, punitive and compensatory relief and attorneys’ fees and costs; and 
 (u) the United States Constitution. 

Employee understands and agrees that Employee is releasing CCC from any and all claims by which Employee is giving up the opportunity to recover any
compensation, damages, or any other form of relief in any proceeding brought by Employee or on Employee’s behalf. Notwithstanding the foregoing, this Release is not intended to operate as a waiver of any retirement or pension benefits that are
vested, the eligibility and entitlement to which shall be governed by the terms of the applicable plan. Nor shall this Release operate to waive or bar any claim or right which — by express or unequivocal terms of law — may not under any
circumstances be waived or barred. 
 2. Definitions. Unless otherwise expressly specified herein, CCC means: 

(a) CCC Intelligent Solutions Holdings, Inc., CCC Intelligent Solutions, Inc., Auto Injury Solutions Inc., CCC Information Services Inc. and
any division thereof, any current or former parent, subsidiary, affiliated entity or related entity, or any predecessors, successors and assigns of any of the foregoing, including specifically CCC. 

 (b) Any current or former officer, director, trustee, agent, employee (as related to their
employment with CCC), shareholder, member, representative, attorney, insurer, or employee benefit or welfare program or plan (including administrators, trustees, fiduciaries, and insurers of such program or plan) of an entity referenced in or
encompassed by Section 2(a) hereof. 
 3. Non-Admission. Employee agrees that this
Release does not render either party the prevailing party in any legal action, and that it is not and shall not be considered an admission of liability or wrongdoing by either party. 

4. No Discrimination, Harassment, Retaliation, Workplace Safety (OSHA) or Workers’ Compensation Claims Pending. Employee
represents and warrants that Employee has not joined, filed or otherwise initiated any cause of action or claim involving discrimination, harassment, retaliation, workplace safety (OSHA) or workers’ compensation against CCC based on events
occurring prior to and including the date Employee executes this Release. Employee further represents and warrants that, as of the date Employee executes this Release, Employee is unaware of any anticipated new lawsuits, charges, complaints, causes
of action or claims against CCC that involve or relate in any way to claims involving discrimination, harassment, retaliation, workplace safety (OSHA) or workers’ compensation arising out of Employee’s employment with CCC. 

5. Disclaimer. Employee states under penalties of perjury that at the time Employee executes this Release: (a) Employee has not
suffered a workplace injury that has not been reported; (b) Employee has been paid properly for all hours worked; (c) other than salary that has accrued during the last and/or current payroll period and will be paid on CCC’s next
regular payroll date, Employee has received all compensation, benefits and payments owed to Employee by CCC with the exception of any payments or benefits to which Employee may become entitled by virtue of the Employment Agreement; (d) Employee
has not sold, assigned, or transferred any Claims, in whole or in part, which are the subject of this Release; (e) Employee has not made, asserted and/or initiated any claim of discrimination, harassment or retaliation, and that this Release
does not have the purpose or effect of concealing details relating to a claim of discrimination, harassment or retaliation. 
 6.
Severability. The invalidity or unenforceability of any provision of this Release shall not affect the validity or enforceability of any other provision of this Release. 

7. Governing Law. This Release shall be governed by and construed and interpreted in accordance with the laws of the State of Delaware
(without regard to principles of conflicts of laws), and all questions relating to the validity and performance hereof and remedies hereunder shall be determined in accordance with such law. 

8. Counterparts. This Release may be executed by facsimile in two counterparts, each of which shall be deemed an original, but both of
which taken together shall constitute one and the same Release. 
 [signature page follows] 

 BY SIGNING THIS RELEASE, EMPLOYEE STATES THAT EMPLOYEE HAS READ IT, UNDERSTANDS IT AND KNOWS THAT
EMPLOYEE IS GIVING UP IMPORTANT RIGHTS. EMPLOYEE AGREES TO ALL THE TERMS CONTAINED WITHIN THIS RELEASE AND IS AWARE OF EMPLOYEE’S RIGHT TO CONSULT WITH AN ATTORNEY BEFORE SIGNING IT, HAS CONSULTED WITH EMPLOYEE’S ATTORNEY (IF EMPLOYEE
CHOSE TO DO SO) BEFORE SIGNING IT AND HAS SIGNED IT KNOWINGLY AND VOLUNTARILY. 
 Employee understands and agrees that this Release may not be
executed by Employee prior to the Effective Date (as defined in the Employment Agreement). 
 Barrett J. Callaghan 

By:
                                         
                    
 Execution Date:
                                        

 Employee understands and agrees that this Release may not be re-executed by Employee prior to the expiration
of the Period of Employment (as defined in the Employment Agreement). 
 Barrett J. Callaghan 

By:
                                         
                    

Re-Execution Date:Exhibit 10.6

 

AMENDED AND RESTATED UNIT PRIVATE PLACEMENT
AGREEMENT

 

This Amended and Restated Unit Private Placement
Agreement (this “Agreement”) is entered into as of February 4, 2022, by and between Hudson Acquisition I Corp., a Delaware
corporation (the “Company”) and Hudson SPAC Holding LLC, a Delaware limited liability company (the “Purchaser”).
Each of the Company and Purchaser shall be referred to as a “Party” and collectively, the “Parties”.

 

RECITALS

 

WHEREAS, the Parties entered into certain Unit
Private Placement Agreement dated April 28, 2021 (the “Original Agreement”), pursuant to which the Purchaser agreed
to purchase from the Company on the Closing Date 420,000 Initial Units at $10.00 per Initial Unit in connection with the Company’s
initial public offering (the “IPO”) originally contemplated in the amount of $100,000,000;

 

WHEREAS, the Company has determined to change
the base size of the IPO to $60,000,000;

 

WHEREAS, each Party agrees that the Original Agreement
is hereby terminated as of the date hereof, shall be of no further force or effect and completely replaced by this Agreement;

 

WHEREAS, as a result of such
changes, the Parties desire to enter into this amended and restated unit private placement agreement to amend the Original Agreement.

 

NOW, THEREFORE, in consideration
of the promises and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:

 

1. Agreement to Subscribe

 

1.1. Purchase and Issuance
of the Initial Units. For the aggregate sum of $3,400,000 (the “Initial Purchase Price”), upon the terms
and subject to the conditions of this Agreement, the Purchaser hereby agrees to purchase from the Company, and the Company hereby agrees
to sell to the Purchaser, on the Closing Date (as defined in Section 1.2) 340,000 units (the “Initial Units”) at $10.00
per Initial Unit.

 

In addition to the foregoing,
the Purchaser hereby agrees to purchase up to an additional 27,000 Units (“Additional Units” and together with
the Initial Units, the “Units”) at $10.00 per Additional Unit for a purchase price of $270,000 (the “Additional
Purchase Price” and together with the Initial Purchase Price, the “Purchase Price”). The purchase
and issuance of the Additional Units shall occur only in the event that the underwriters’ 45-day over-allotment option (“Over-Allotment
Option”) in the Offering is exercised in full or part. The total number of Additional Units to be purchased hereunder shall
be in the same proportion as the amount of the Over-Allotment Option that is exercised. Each purchase of Additional Units shall occur
simultaneously with the consummation of any portion of the Over-Allotment Option.

 

     

     

    

 

1.2.
Closing. The closing (the “Closing”) of the Offering shall take place at the offices of Sichenzia Ross
Ference LLP, 1185 Avenue of the Americas, 31st Floor, New York, New York, 10036 simultaneously with the consummation of the
Company’s IPO of six million (6,000,000) units consisting of one share of common stock of the Company, par value $0.0001
per share (the “Common Shares”), and one right (the “Right”) to receive one-tenth
(1/10) of one Common Share (the “Right Shares”) to be governed by the Rights Agreement (defined herein) and
the consummation of the exercise of all or any portion of the Over-Allotment Option (each a “Closing Date”).

 

1.3. Delivery of the Purchase
Price. At least one business day prior to the effective date of the Company’s registration statement relating to the IPO (“Registration
Statement”), or the date of the exercise of the Over-Allotment Option, if any, the Purchaser agrees to deliver the Initial
Purchase Price or Additional Purchase Price, as the case may be, by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars to an escrow agent to be identified prior to the Closing (“Escrow Agent”), which
is hereby irrevocably authorized to deposit such funds on the applicable Closing Date to the trust account which will be established for
the benefit of the Company’s public shareholders, managed pursuant to that certain Investment Management Trust Agreement to be entered
into by and between the Company and Escrow Agent and into which substantially all of the proceeds of the IPO will be deposited (the “Trust
Account”). If the IPO is not consummated within 14 days of the date the Initial Purchase Price is delivered to Escrow Agent,
the Initial Purchase Price shall be returned to the Purchaser by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars, without interest or deduction.

 

1.4. Delivery of Unit Certificate.
Upon the applicable Closing Date after delivery of the Purchase Price in accordance with Section 1.3, the Purchaser shall become irrevocably
entitled to receive a unit certificate representing the Units purchased hereunder.

 

2. Representations and
Warranties of the Purchaser

 

The Purchaser represents and warrants to the Company that:

 

2.1. No Government Recommendation
or Approval. It understands that no United States federal or state agency or a similar agency of any other country has passed upon
or made any recommendation or endorsement of the Company, the Offering, the Units, the Rights, the Right Shares, or the Common Shares
underlying the Units (excluding the Right Shares, the “Unit Shares” and, collectively with the Units and the
Right Shares, the “Securities”).

 

2.2. Organization.
The Purchaser is a company, validly existing and in good standing under the laws of its jurisdiction and possesses all requisite power
and authority necessary to carry out the transactions contemplated by this Agreement.

 

    2

     

    

 

2.3. Private Offering.
It is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as
amended (the “Securities Act”). It acknowledges that the sale contemplated hereby is being made in reliance on a private placement
exemption to “Accredited Investors” within the meaning of Section 501(a) of Regulation D under the Securities Act.

 

2.4. Authority.
This Agreement has been validly authorized, executed and delivered by the Purchaser and is a valid and binding agreement enforceable in
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or
similar laws affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless of
whether enforcement is sought in a proceeding at law or in equity).

 

2.5. No Conflicts. The
execution, delivery and performance of this Agreement and the consummation by the Purchaser of the transactions contemplated hereby do
not violate, conflict with or constitute a default under (i) the Purchaser’s organizational documents, (ii) any agreement, indenture
or instrument to which the Purchaser is a party or (iii) any law, statute, rule or regulation to which the Purchaser is subject, or any
agreement, order, judgment or decree to which the Purchaser is subject.

 

2.6. No Legal Advice
from Company. It acknowledges it has had the opportunity to review this Agreement and the transactions contemplated by this Agreement
and the other agreements entered into between the parties hereto with its own legal counsel and investment and tax advisors. Except for
any statements or representations of the Company made in this Agreement and the other agreements entered into between the parties hereto,
it is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of its representatives
or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.

 

2.7. Access to Information;
Independent Investigation. Prior to the execution of this Agreement, it has had the opportunity to ask questions of and receive answers
from representatives of the Company concerning an investment in the Company, as well as the finances, operations, business and prospects
of the Company, and the opportunity to obtain additional information to verify the accuracy of all information so obtained. In determining
whether to make this investment, it has relied solely on its own knowledge and understanding of the Company and its business based upon
its own due diligence investigation and the information furnished pursuant to this paragraph. It understands that no person has been authorized
to give any information or to make any representations which were not furnished pursuant to this Section 2 and it has not relied on any
other representations or information in making its investment decision, whether written or oral, relating to the Company, its operations
and/or its prospects.

 

2.8. Reliance on Representations
and Warranties. It understands the Units are being offered and sold to it in reliance on exemptions from the registration requirements
under the Securities Act, and analogous provisions in the laws and regulations of various states, and that the Company is relying upon
the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Purchaser set forth in
this Agreement in order to determine the applicability of such provisions.

 

    3

     

    

 

2.9. No Advertisements.
It is not subscribing for the Units as a result of or subsequent to any advertisement, article, notice or other communication published
in any newspaper, magazine, or similar media or broadcast over television or radio, or presented at any seminar or meeting.

 

2.10. Legend.
It acknowledges and agrees the certificates evidencing the Units, the Common Shares, the Rights and the Common Shares underlying the Rights
shall bear a restrictive legend (the “Legend”), in form and substance as set forth in Section 4 hereof, prohibiting
the offer, sale, pledge or transfer of the securities, except (i) pursuant to an effective registration statement covering these securities
under the Securities Act or (ii) pursuant to any other exemptions from the registration requirements under the Securities Act and such
laws which, in the opinion of counsel for the Company, is available.

 

2.11. Experience, Financial
Capability and Suitability. It is (i) sophisticated in financial matters and is able to evaluate the risks and benefits of the investment
in the Securities and (ii) able to bear the economic risk of his investment in the Securities for an indefinite period of time because
the Securities have not been registered under the Securities Act and therefore cannot be sold unless subsequently registered under the
Securities Act or an exemption from such registration is available. It has substantial experience in evaluating and investing in transactions
of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company
and has the capacity to protect its own interests. It has substantial experience in evaluating and investing in transactions of securities
in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has
the capacity to protect its own interests.

 

2.12. Investment Purposes.
It is purchasing the Securities solely for investment purposes, for its own account and not for the account or benefit of any other person,
and not with a view towards the distribution or dissemination thereof and it has no present arrangement to sell the interest in the Securities
to or through any person or entity.

 

2.13. Restrictions on Transfer.
It acknowledges and understands the Units are being offered in a transaction not involving a public offering in the United States within
the meaning of the Securities Act. The Securities have not been registered under the Securities Act, and, if in the future, it decides
to offer, resell, pledge or otherwise transfer the Securities, such Securities may be offered, resold, pledged or otherwise transferred
only

 

(A) pursuant to an effective registration statement
filed under the Securities Act,

 

(B) pursuant to an exemption
from registration under Rule 144 promulgated under the Securities Act (“Rule 144”), if available, or

 

    4

     

    

 

(C) pursuant to any other
available exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable securities
laws of any state or any other jurisdiction. It agrees that if any transfer of its Securities or any interest therein is proposed to be
made, as a condition precedent to any such transfer, it may be required to deliver to the Company an opinion of counsel satisfactory to
the Company. Absent registration or another available exemption from registration, it agrees it will not resell the Securities. It further
acknowledges that because the Company is a shell company, Rule 144 may not be available to it for the resale of the Securities until the
one year anniversary following consummation of the initial Business Combination (defined below) of the Company, despite technical compliance
with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions.

 

3. Representations and
Warranties of the Company

 

The Company represents and warrants to the Purchaser that:

 

3.1. Valid Issuance of Share
Capital. The total number of all classes of share capital which the Company has authority to issue is 200,000,000 shares of common
stock. As of the date hereof, the Company has issued 1,725,000 Common Shares (225,000 shares of which are subjected to forfeiture and
none are subject to redemption as described in the registration statement related to the IPO). All of the issued share capital of the
Company has been duly authorized, validly issued, and are fully paid and non-assessable.

 

3.2. Title to Securities.
Upon issuance in accordance with, and payment pursuant to, the terms hereof, the rights agreement to be entered into with Escrow Agent
on or prior to the closing of the IPO (the “Rights Agreement”), as the case may be, each of the Rights and the
Common Shares will be duly and validly issued, fully paid and non-assessable. On the date of issuance of the Units and the Right Shares
shall have been reserved for issuance. Upon issuance in accordance with the terms hereof and the Rights Agreement, the Purchaser will
have or receive good title to the Right Shares, free and clear of all liens, claims and encumbrances of any kind other than (i) transfer
restrictions hereunder and pursuant to the insider letter to be entered into on or prior to the closing of the IPO (the “Insider
Letter”) and (ii) transfer restrictions under federal and state securities laws.

 

3.3. Organization
and Qualification. The Company has been duly incorporated and is validly existing as a Delaware business company and has the requisite
corporate power to own its properties and assets and to carry on its business as now being conducted.

 

3.4. Authorization; Enforcement.
(i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to
issue the Securities in accordance with the terms hereof, (ii) the execution, delivery and performance of this Agreement by the Company
and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary corporate action and no
further consent or authorization of the Company or its Board of Directors or shareholders is required, and (iii) this Agreement constitutes,
and upon the execution and delivery thereof, the Rights and Rights Agreement, will constitute, valid and binding obligations of the Company
enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement
of, creditors’ rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity
and contribution may be limited by federal and state securities laws or principles of public policy.

 

    5

     

    

 

3.5 No Conflicts.
The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby
do not (i) result in a violation of the Company’s bylaws and Certificate of Incorporation, conflict with, or constitute a default
under any agreement, indenture or instrument to which the Company is a party or (iii) conflict with any law, statute, rule or regulation
to which the Company is subject or any agreement, order, judgment or decree to which the Company is subject. Other than any federal, state
or foreign securities filings which may be required to be made by the Company subsequent to the Closing, and any registration statement
which may be filed pursuant thereto, the Company is not required under federal, state or local law, rule or regulation to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity in order
for it to perform any of its obligations under this Agreement or issue the Units, the Rights or the Common Shares underlying the Units,
Rights in accordance with the terms hereof.

 

4. Legends

 

4.1. Legend.
The Company will issue the Units, the Rights and the Unit Shares, and when issued, the Right Shares purchased by the Purchaser, in the
name of the Purchaser. The Securities will bear the following Legend and appropriate “stop transfer” instructions:

 

THESE SECURITIES (i) HAVE NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT, (B)
TO A NON-U.S. PERSON IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (C)
PURSUANT TO THE RESALE LIMITATIONS SET FORTH IN RULE 905 OF REGULATION S UNDER THE SECURITIES ACT, (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION
PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) OR (E) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION.
HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO AN AGREEMENT BETWEEN HUDSON ACQUISITION I CORP. AND HUDSON SPAC HOLDING, LLC AND MAY NOT BE OFFERED, SOLD, TRANSFERRED,
PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP PURSUANT TO THE TERMS SET FORTH THEREIN.”

 

    6

     

    

 

4.2. Purchaser’s Compliance.
Nothing in this Section 4 shall affect in any way the Purchaser’s obligations and agreements to comply with all applicable securities
laws upon resale of the Securities.

 

4.3. Company’s Refusal
to Register Transfer of the Securities. The Company shall refuse to register any transfer of the Securities, if in the sole judgment
of the Company such purported transfer would not be made (i) pursuant to an effective registration statement filed under the Securities
Act, or (ii) pursuant to an available exemption from the registration requirements of the Securities Act.

 

4.4. Registration
Rights. The Purchaser will be entitled to certain registration rights which will be governed by a registration rights agreement (“Registration
Rights Agreement”) to be entered into with the Company on or prior to the closing of the IPO.

 

5. Lockup

 

The Purchaser acknowledges
and agrees that the Units, the Rights, the Unit Shares, and the Right Shares shall not be transferable, saleable or assignable until thirty
(30) days after the consummation of an acquisition, share exchange, purchase of all or substantially all of the assets of, or any other
similar business combination with one or more businesses or entities (a “Business Combination”), except to permitted
transferees (as defined in the Insider Letter).

 

6. Securities Laws Restrictions

 

The Purchaser agrees not to
sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Securities unless, prior thereto (a) a registration
statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Securities proposed
to be transferred shall then be effective or (b) the Company shall have received an opinion from counsel reasonably satisfactory to the
Company, that such registration is not required because such transaction complies with the Securities Act and the rules promulgated by
the Securities and Exchange Commission thereunder and with all applicable state securities laws.

 

7. Waiver of Distributions
from Trust Account

 

In connection with the Securities
purchased pursuant to this Agreement, the Purchaser hereby waives any and all right, title, interest or claim of any kind in or to any
distributions from the Trust Account.

 

    7

     

    

 

8. Rescission Right Waiver
and Indemnification

 

8.1. Rescission Waiver.
The Purchaser understands and acknowledges that an exemption from the registration requirements of the Securities Act requires there be
no general solicitation of purchasers of the Units. In this regard, if the Offering were deemed to be a general solicitation with respect
to the Units, the offer and sale of such Units may not be exempt from registration and, if not, the Purchaser may have a right to rescind
its purchase of the Units. In order to facilitate the completion of the Offering and in order to protect the Company, its shareholders
and the Trust Account from claims that may adversely affect the Company or the interests of its shareholders, the Purchaser hereby agrees
to waive, to the maximum extent permitted by applicable law, any claims, right to sue or rights in law or arbitration, as the case may
be, to seek rescission of its purchase of the Units as a result of the issuance of the Units being deemed to be in violation of Section
5 of the Securities Act. The Purchaser acknowledges and agrees this waiver is being made in order to induce the Company to sell the Units
to the Purchaser. The Purchaser agrees the foregoing waiver of rescission rights shall apply to any and all known or unknown actions,
causes of action, suits, claims or proceedings (collectively, “Claims”) and related losses, costs, penalties,
fees, liabilities and damages, whether compensatory, consequential or exemplary, and expenses in connection therewith, including reasonable
attorneys’ and expert witness fees and disbursements and all other expenses reasonably incurred in investigating, preparing or defending
against any Claims, whether pending or threatened, in connection with any present or future actual or asserted right to rescind the purchase
of the Units hereunder or relating to the purchase of the Units and the transactions contemplated hereby.

 

8.2. No Recourse Against
Trust Account. The Purchaser agrees not to seek recourse against the Trust Account for any reason whatsoever in connection with its
purchase of the Units or any Claim that may arise now or in the future.

 

8.3. Section 8 Waiver.
The Purchaser agrees that to the extent any waiver of rights under this Section 8 is ineffective as a matter of law, the Purchaser has
offered such waiver for the benefit of the Company as an equitable right that shall survive any statutory disqualification or bar that
applies to a legal right. The Purchaser acknowledges the receipt and sufficiency of the consideration received from the Company hereunder
in this regard.

 

9. Terms of the Unit

 

The Units shall be substantially
identical to the Units offered in the IPO as set forth in the Underwriting Agreement, except the Units: (i) will be subject to the transfer
restrictions described herein, and (ii) are being purchased pursuant to an exemption from the registration requirements of the Securities
Act and will become freely tradable only after certain conditions are met or the resale of the Units is registered under the Securities
Act.

 

10. Governing Law; Jurisdiction;
Waiver of Jury Trial

 

This Agreement shall be governed
by and construed in accordance with the laws of Delaware for agreements made and to be wholly performed within such territory. The parties
hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions contemplated
hereby.

 

11. Assignment; Entire
Agreement; Amendment

 

11.1. Assignment.
Neither this Agreement nor any rights hereunder may be assigned by any party to any other person other than by the Purchaser, without
the prior consent of the Company, to one or more persons agreeing to be bound by the terms hereof. Upon such assignment by a Purchaser,
the assignee(s) shall become Purchaser hereunder and have the rights and obligations provided for herein to the extent of such assignment.

 

    8

     

    

 

11.2. Entire Agreement.
This Agreement sets forth the entire agreement and understanding between the parties as to the subject matter hereof and supersedes any
and all prior discussions, agreements and understandings of any and every nature.

 

11.3. Amendment. Except
as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other
than by a written instrument signed by the party against whom enforcement of any such amendment, waiver, discharge or termination is sought.

 

11.4. Binding upon
Successors. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal
representatives, successors and permitted assigns.

 

12. Notices; Indemnity

 

12.1 Notices. All notices,
requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party’s address set
forth herein or to such other address as a party may designate by notice hereunder, and shall be either (a) delivered by hand, (b) sent
by overnight courier, or (c) sent by certified mail, return receipt requested, postage prepaid. All notices, requests, consents and other
communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the receiving
party at the address of such party set forth above, (ii) if sent by overnight courier, on the next business day following the day such
notice is delivered to the courier service, or (iii) if sent by certified mail, on the fifth business day following the day such mailing
is made.

 

12.2 Indemnification.
Except as set forth in Section 8, each party shall indemnify the other party against any loss, cost or damages (including reasonable attorney’s
fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement set forth
in this Agreement.

 

13. Counterparts

 

This Agreement may be executed
in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such signature page were an original thereof.

 

    9

     

    

 

14. Survival; Severability

 

14.1. Survival. The
representations, warranties, covenants and agreements of the parties hereto shall survive the Closing until one (1) year following the
consummation of an initial Business Combination.

 

14.2. Severability.
In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, this Agreement shall continue in full force and effect without said provision; provided that no such severability shall be effective
if it materially changes the economic benefit of this Agreement to any party.

 

15. Headings

 

The titles and subtitles used
in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

16. Construction

 

The parties hereto have participated
jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement
will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring
any party hereto because of the authorship of any provision of this Agreement. The words “include,” “includes,”
and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine,
and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural
and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to
any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained
herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein
in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless
of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party
hereto is in breach of the first representation, warranty, or covenant.

 

[Remainder of page intentionally left blank]

 

    10

     

    

 

 

This subscription is accepted by the Company as of the date first written
above.

 

	HUDSON ACQUISITION I CORP.	 
	 	 	 
	By:	 	 
	Name: 	Jiang Hui	 
	Title: 	Chief Executive Officer	 

 

Accepted and agreed this 4th day of February, 2022

 

	HUDSON SPAC HOLDING, LLC	 
	 	 	 
	By:	 	 
	Name: 	Xiaoyue Zhang	 
	Title: 	Authorized Signatory	 
	  	 

 

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]